Spots Global Cancer Trial Database for A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer
Official Title: A Clinical Pharmacological Study to Assess the Distribution, Metabolism, and Elimination of YM155 After i.v. Infusion in Patients With Advanced Cancer
Study ID: NCT01023386
Conditions
Interventions
Study Description
Brief Summary: This study investigates the pharmacokinetics of YM155, identifies the metabolic profile of YM155 and evaluates the safety and tolerability of YM155 after a 3-hour infusion in patients with advanced cancer
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Budapest, , Hungary
Contact Details
Name: Use Central Contact
Affiliation: Astellas Pharma Europe B.V.
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
